Cannovum AG

Company Description

---

The legalization of cannabis in Germany will create a billion-euro market for a modern stimulant that has proven its positive effects many times over. Cannovum is one of the market leaders in the industry and thus has the ideal starting position to shape the cannabis revolution.

The well-being of people is a topic close to our hearts. Today, we already provide thousands of patients with high-quality medical cannabis. More than 10 percent of all German cannabis-distributing pharmacies are our regular customers. Trust in Cannovum means trust in quality, experience and expertise.

Cannovum is the first fully licensed cannabis company on the German stock market. With legalization of recreational cannabis, the market is on the verge of a revolution, with an estimated market potential of 8 billion euros - in Germany alone. As one of the market leaders in medical cannabis, Cannovum is optimally prepared for this.

Year founded

---

2018

Served area

---

Germany

Headquarters

---

Rheinsberger Str. 76/77, 10115 Berlin – Germany

Shares outstanding

---

2,540,000

IPO

---

Dec. 15, 2022

Stock exchange(s)

---

Frankfurt Stock Exchange